Esperion Therapeutics (ESPR) P/B (2013 - 2026)
Esperion Therapeutics (ESPR) P/B from Jun 26, 2013 to Jul 13, 2026. The TTM Esperion Therapeutics (ESPR) P/B is -2.60. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Esperion Therapeutics (ESPR)
| Year | P/B | Change |
|---|---|---|
| 2026 | -2.60 | +5.53% |
| 2025 | -2.46 | +122.95% |
| 2024 | -1.10 | +35.23% |
| 2023 | -0.82 | -43.20% |
| 2022 | -1.44 | +113.85% |
| 2021 | -0.67 | -91.09% |
| 2020 | -7.53 | -109.17% |
| 2019 | 82.19 | +427.00% |
| 2018 | 15.60 | +151.55% |
| 2017 | 6.20 | +458.08% |
| 2016 | 1.11 | -36.33% |
| 2015 | 1.74 | -71.68% |
| 2014 | 6.16 | -86.78% |
| 2013 | 46.61 | N/A |
Comparison Esperion Therapeutics (ESPR) P/B with competitors
Esperion Therapeutics (ESPR) P/B is -2.60.